Effect of cardiovascular drugs on adenosine deaminase activity

Angiology

Volumn 59, Issue 6, 2009, Pages 740-744

  Kowalczyk, Edward ^a   Kopff, Maria ^a   Kowalski, Jan ^a   Kopff, Anna ^c   Mikhailidis, Dimitri P ^b   Barylski, Marcin ^a   Banach, MacIej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NONE

Author keywords

Adenosine deaminase; Aspirin; Isoenzymes; Metoprolol and isosorbide mononitrate; Molsidomine; Simvastatin

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; ADENOSINE DEAMINASE; ISOSORBIDE MONONITRATE; METOPROLOL; MOLSIDOMINE; SIMVASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; MALE; NONHUMAN; PLASMA; RABBIT;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; CARDIOVASCULAR AGENTS; DOWN-REGULATION; ERYTHROCYTES; FEMALE; HALF-LIFE; ISOENZYMES; MALE; RABBITS;

EID: 57749200252     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708323495     Document Type: Article

References (31)

1. Cronstein BN, Levin RI, Belanoff J., Weissmann G., Hirschorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest. 1986 ; 78: 760-770.
2. Cronstein BN, Kramer SB, Weissmann G., Hischhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med. 1983 ; 158: 1160-1177.
3. Olsson RA, Pearson JD Cardiovascular purinoreceptors. Physiol Rev. 1990 ; 70: 761-845.
4. Ohisalo JJ Regulation function of adenosine. Med Biol. 1987 ; 65: 181-186.
5. Nees S., Des Rosiers C., Bock M. Adenosine receptors at the coronary endothelium. Functional implication. In: Gerlach E, Becker BF, eds. Topics and Perspectives in Adenosine Research. Berlin: Springer-Verlag ; 1987 ; 454-469.
6. Fox JH, Kelly WN The role of adenosine and 2'-deoxyadenosine in mammalian cells. Ann Rev Biochem. 1978 ; 47: 655-686.
7. Schrader WP, Stacy AR Purification of adenosine deaminase complexing protein from human plasma. J Biol Chem. 1979 ; 254: 11964-11968.
8. Ungerer JPJ, Oosthuizen HM, Bissbort SH, Vermaak WJH. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem. 1992 ; 38: 1322-1326.
9. Ratech H., Hirschhorn R. Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficiency-severe combined immunodeficiency. Clin Chim Acta. 1981 ; 115: 341-347.
10. Ratech H., Thorbecke GJ, Meredith G., Hirschhorn R. Comparison and possible homology of isoenzymes of adenosine deaminase in aves and humans. Enzyme. 1981 ; 26: 74-84.
11. Giusti G., Galanti B. Adenosine deaminase. Colorimetric method. In: Bergmeyer HU, ed., Methods of Enzymatic Analysis. vol 4, 3 rd ed. Weinheim: Verlag Chemie ; 1984 ; 315-323.
12. Gakis C. Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J. 1996 ; 9: 632-633.
13. Hopkinson DA, Cook PJL, Harris H. Further data on the adenosine deaminase polymorphism and report of new phenotype. Ann Hum Genet. 1969 ; 32: 361-367.
14. Muraoka T., Katsuramaki T., Shiraishi H., Yokoyama MM Automated enzymatic measurement of adenosine deaminase isoenzyme activities in serum. Anal Biochem. 1990 ; 187: 268-272.
15. Herrera C., Casado V., Ciruela F., et al. Adenoine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol Pharmacol. 2001 ; 59: 127-134.
16. Melzig M., Paun I. Modulation of adenosine deaminase activity of endothelial cells by steroids. Pharmazie. 1992 ; 47: 394.
17. Bottini N., Gloria-Bottini F., Borgiani P., Antonacci E., Lucarelli P., Bottini E. Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms. Metabolism. 2004 ; 53: 995-1001.
18. Centells JJ, Franco R., Bozal J. Purification and partial characterization of brain Adenosine deaminase. Inhibition by purine compounds and by drugs. Neurosci Res. 1988 ; 19: 258-267.
19. Koch HP, Jager W., Groh U., et al. Carbohydrates from garlic bulbs (allium sativum L.) as inhibitors of adenosine deaminase enzym activity. Phytotherapy Res. 1993 ; 7: 387-389.
20. Melzig MF, Krause E., Franke S. Inhibition of adenosine deaminase activity of aortic endothelial cells by extracts of garlic (allium sativum L.). Pharmazie. 1995 ; 50: 359-362.
21. Koch HP, Aichinger A., Bohne B., Plank G. In vitro inhibition of adenosine deaminase by a group of steroid and triterpenoid compounds. Phytother Res. 1994 ; 8: 109-111.
22. Koch HP, Jager W., Groh U., Plank G. In vitro inhibition of adenosine deaminase by flavonoid and related compounds. New insight into the mechanism of action of plant phenolics. Meth Find Exp Clin Pharmacol. 1992 ; 14: 413-417.
23. Ajloo D., Saboury AA, Haghi-Asli N., et al. Kinetic, thermodynamic and statistical studies on the inhibition of adenosine deaminase by aspirin and diclofenac. J Enzyme Inhib Med Chem. 2007 ; 22: 395-406.
24. Gilbertsen RB Effects of pentostatin (2'-deoxycoformicin) an inhibitor of adenosine deaminase, on the II collagen induced arthritis in rats. J Immunol. 1985 ; 7: 325-341.
25. Barankiewicz J., Danks A., Marangos PJ Can adenosine deaminase inhibitors be cytoprotective agents? In: Griesmacher et al, ed., Purine and pyrimidine metabolism in man. IX. New York: Plenum Press; 1998: 395-399.
26. Saito D., Abe Y., Tani H., et al. Effect of adenosine deaminase inhibitors on myocardial reactive hyperaemia following brief coronary occlusions. Cardiovasc Res. 1985 ; 19: 578-583.
27. Banach M., Drozdz J., Okonski P., Rysz J. Immunological aspects of the statins' function in patients with heart failure. A report from the Annual Conference of ESC-Heart Failure 2005. Cell Mol Immunol. 2005 ; 2: 433-437.
28. Heusch P., Skyschally A., Leineweber K., Haude M., Erbel R., Heusch G. The interaction of coronary microembolization and ischemic preconditioning: a third window of cardioprotection through TNF-alpha. Arch Med Sci. 2007 ; 3: 83-92.
29. Schipke JD, Halkos ME, Kerendi F., Gams E., Vinten-Johansen J. Postconditioning: a brief review. Arch Med Sci. 2006 ; 2: 137-145.
30. Safranow K., Rzeuski R., Binczak-Kuleta A., et al. ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease. Cardiology. 2007 ; 108: 275-281.
31. Banach M., Mikhailidis DP, Ugurlucan M., et al. The significance of statin use in patients subjected to surgical coronary revascularization. Arch Med Sci. 2007 ; 3: S126 - S132.